n-methyl-3,4-methylenedioxyamphetamine has been researched along with Briquet Syndrome in 3 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Problematic ecstasy users reported significantly higher levels of ecstasy use, including lifetime consumption, average dosage and binge consumption compared to non-problematic ecstasy users." | 1.33 | Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors. ( Parrott, AC; Soar, K; Turner, JJ, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Senon, JL | 1 |
| Lafay, N | 1 |
| Padet, N | 1 |
| Milani, RM | 1 |
| Parrott, AC | 2 |
| Turner, JJ | 2 |
| Fox, HC | 1 |
| Soar, K | 1 |
1 review available for n-methyl-3,4-methylenedioxyamphetamine and Briquet Syndrome
| Article | Year |
|---|---|
[Medication-induced psychoses].
Topics: Cannabis; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Psychoses, Substance-Induce | 2003 |
2 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Briquet Syndrome
| Article | Year |
|---|---|
Gender differences in self-reported anxiety, depression, and somatization among ecstasy/MDMA polydrug users, alcohol/tobacco users, and nondrug users.
Topics: Adult; Amphetamine-Related Disorders; Analysis of Variance; Anxiety Disorders; Depressive Disorder; | 2004 |
Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Anxiety Disorders; Comorbidity; Depressive Disorde | 2006 |